Research on botanical compounds and the ACE2 receptor
A study by researchers at the University of Lethbridge analyzed the potential effect of certain bioactive plant-derived compounds on the interaction of the virus with human cells.
The research evaluated more than 400 plant strains and found that some of them could influence the expression of the ACE2 receptor (Angiotensin-Converting Enzyme II), one of the main viral entry points in tissues such as lungs, intestines, and mucous membranes.
In three-dimensional human tissue models, certain strains significantly reduced the activity of this receptor, which could decrease cellular vulnerability to certain infectious agents.
The role of therapeutic botanical oil
Among the evaluated compounds, the well-known therapeutic botanical oil (derived from specific plant extracts) stood out for its ability to modulate certain cellular mechanisms without generating psychotropic effects.
These types of extracts have been used for years within complementary wellness approaches and continue to be the subject of scientific research for their potential regulatory role at the cellular level.
Does this mean it's a treatment?
No. Researchers emphasize that these findings do not replace vaccines or medical treatments. These are preliminary studies that seek to better understand how certain plant compounds interact with specific cellular mechanisms.
As with all early-stage research, the results should be interpreted with caution and within an appropriate scientific context.
Conclusion
Research on botanical extracts and their interaction with cellular receptors continues to advance. Although the laboratory results are promising, further clinical studies are still needed to determine their actual scope.
The growing interest in complementary natural solutions reflects a trend towards holistic well-being and the scientific exploration of plant-derived compounds.
